BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18942627)

  • 1. Regional differences in the use of sentinel lymph node biopsy for melanoma: a potential quality measure.
    Lane K; Kempf A; Magno C; Lane J; Butler J; Hsiang D; Greenfield S; Jakowatz J
    Am Surg; 2008 Oct; 74(10):981-4. PubMed ID: 18942627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
    Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
    J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
    Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
    Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in melanoma patients.
    Lens M
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1005-12. PubMed ID: 20158587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
    Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
    Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma.
    Shah DR; Yang AD; Maverakis E; Martinez SR
    J Surg Res; 2013 Oct; 184(2):1157-60. PubMed ID: 23768765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
    Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
    Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of regression in primary melanoma with sentinel lymph node status.
    Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
    J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
    Wasif N; Gray RJ; Bagaria SP; Pockaj BA
    Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
    Bower M; Scoggins CR
    J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
    Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
    Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sentinel node biopsy in patients with cutaneous melanoma.
    Aldredge LM
    Nurs Clin North Am; 2007 Sep; 42(3):379-92, v-vi. PubMed ID: 17825660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in melanoma.
    Hueman MT; Lange JR
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):243-50. PubMed ID: 18998214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database.
    Sperry SM; Charlton ME; Pagedar NA
    JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1101-9. PubMed ID: 25321889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
    Avilés-Izquierdo JA; Lázaro-Ochaita P
    Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck melanoma in the sentinel lymph node era.
    Agnese DM; Maupin R; Tillman B; Pozderac RD; Magro C; Walker MJ
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1121-4. PubMed ID: 18025316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.